cbdMD, a leading hemp wellness company listed on NYSE American, welcomed the U.S. Administration's push for fair federal treatment of hemp-derived products and urged Congress to adopt clear regulations. The Administration's call aims to protect consumer access to full-spectrum CBD while ensuring safety, reflecting growing federal support for the hemp sector. Meanwhile, major U.S. exchanges are allowing compliant cannabis operators to list, signaling increased legitimacy and regulatory maturity in the cannabinoid market. cbdMD believes its established position and transparent practices position it well for growth as the industry evolves.
Moore Law, PLLC is investigating BellRing Brands, Inc. for allegedly misrepresenting its sales growth as driven by increased consumer demand, while it was actually due to key customers stockpiling inventory. The company reportedly downplayed competit...
An insider at Progyny (PGNY) sold 5,500 shares valued at $137,000. Insider sales can indicate the insider's personal financial decisions or a signal about the company's future prospects. Investors often watch such moves closely to gauge confidence le...
Law Offices of Howard G. Smith announced class action lawsuits against Calix, AeroVironment, Zoetis, and Lucid Group for allegedly making false or misleading statements about their business conditions and prospects during specific periods in 2025 and...
TALON and Smart Data Solutions (SDS) have deepened their partnership to extend TALON's Universal Repricer and UAPA™ pricing technology across SDS's EDI clearinghouse. This expansion allows more health plans, TPAs, and self-funded employers to apply e...
DraftKings shares have dropped significantly over the past year but showed promise in Q1 2026 with revenue and earnings beating expectations. The stock faces challenges from ongoing litigation and regulatory scrutiny, yet benefits from expanding spor...
